Find-A-Study

Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas

Lay Description

This clinical trial studies blood sample markers of reproductive hormones in assessing ovarian reserve in younger patients with newly diagnosed lymphomas. Studying samples of blood from patients with cancer in the laboratory may help measure the effect of curative therapy for lymphoma on ovarian failure.

Eligibility

Eligible Ages: Under29 Years
Eligible Genders: Female
Accepts Healthy Volunteers: No

Inclusion Criteria

Patients must have had first menses >= 6 months prior to enrollment
Patients must be newly diagnosed with lymphoma; this includes but is not limited to Hodgkin lymphoma, Burkitts lymphoma, diffuse large B cell lymphoma, and anaplastic large cell lymphoma
Planned cancer treatment must include an alkylating agent: i.e. procarbazine, cyclophosphamide, ifosphamide; planned cancer treatment must be less than one year
Patients with any performance status are eligible for enrollment
Patients may take hormone medications excluding gonadotropin-releasing hormone (GnRH) analogues
All patients and/or their parents or legal guardians must sign a written informed consent
All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met

Exclusion Criteria

Patients who have previously received chemotherapy other than steroids and intrathecal chemotherapy are not eligible
Patients who have a secondary malignancy are not eligible
Patients with known history of ovarian disease: e.g. Turner syndrome or polycystic ovarian syndrome are not eligible
Patients in whom planned therapy includes: removal or uterus or ovary(ies), pelvic irradiation, cranial irradiation or hematopoietic stem cell transplantation are not eligible
Patients who previously have had their uterus or ovary(ies) removed are not eligible
Patients who have received gonadotropin release hormone agonist or antagonist (e.g. Lupron) prior to study entry are not eligible
Patients who are pregnant or breast feeding are not eligible
Patients who have undergone or are planning to undergo ovarian tissue, oocyte or embryo cryopreservation prior to treatment are not eligible

Study Design

Arm Groups

Study Contact

Virginia Diaz
(210) 562-9149
diazvr@uthscsa.edu

Principal Investigator
Anne-Marie Langevin